Cargando…

Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial

BACKGROUND AND AIMS: Despite established guidelines on secondary prevention of cardiovascular disease, practical implementation of treatment targets is deficient even in high-income countries. This study compared long-term hospital-based treatment with follow-up at primary health care regarding new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaldal, Anete, Tonstad, Serena, Jortveit, Jarle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679993/ https://www.ncbi.nlm.nih.gov/pubmed/34915839 http://dx.doi.org/10.1186/s12872-021-02426-3

Ejemplares similares

Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial
por: Kaldal, Anete, et al.
Publicado: (2023)

Sex differences in secondary preventive follow-up after coronary heart events
por: Kaldal, Anete, et al.
Publicado: (2023)

Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
por: Jortveit, Jarle, et al.
Publicado: (2019)

Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
por: Halvorsen, Sigrun, et al.
Publicado: (2016)

Are long‐term FAD diets restricting micronutrient intake? A randomized controlled trial
por: Malik, Neal, et al.
Publicado: (2020)

Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway
por: Jortveit, Jarle, et al.
Publicado: (2021)

Remote ECG Monitoring by ECG247 Smart Heart Sensor
por: Jortveit, Jarle, et al.
Publicado: (2022)

Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery
por: Zhang, Heng, et al.
Publicado: (2015)

Paroxysmal Tachycardia Diagnosed by ECG247 Smart Heart Sensor in a Previously Healthy Child
por: Jortveit, Jarle, et al.
Publicado: (2022)

Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial
por: Tønnesen, Philip, et al.
Publicado: (2022)

Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
por: Tonstad, Serena, et al.
Publicado: (2016)

Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013–19
por: Jortveit, Jarle, et al.
Publicado: (2022)

Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
por: Jortveit, Jarle, et al.
Publicado: (2022)

Feasibility of prehospital identification of non-ST-elevation myocardial infarction by ECG, troponin and echocardiography
por: Jacobsen, Lars, et al.
Publicado: (2022)

Heart rhythm assessment in elite endurance athletes: A better method?
por: Ausland, Ådne, et al.
Publicado: (2022)

Practice setting and secondary prevention of coronary artery disease
por: Jankowski, Piotr, et al.
Publicado: (2017)

Room for standardisation: the secondary prevention of coronary artery disease
por: Bahl, Rahul
Publicado: (2021)

Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
por: Husted, Steen
Publicado: (2015)

Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)

Smartphone-guided secondary prevention for patients with coronary artery disease
por: Eckardt, Irina, et al.
Publicado: (2021)

Pharmacoeconomic Analysis of Clopidogrel in Secondary Prevention of Coronary Artery Disease
por: Cheng, Judy W.
Publicado: (2007)

Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry
por: Björklund, Erik, et al.
Publicado: (2020)

Efficacy of Smartphone-Based Secondary Preventive Strategies in Coronary Artery Disease
por: Murphy, Alexandra C, et al.
Publicado: (2020)

Comparison of Secondary Prevention Status between Percutaneous Coronary Intervention and Coronary Artery Bypass Patients
por: Gao, Xia-qing, et al.
Publicado: (2017)

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010)

Severe congenital heart defects: incidence, causes and time trends of preoperative mortality in Norway
por: Wik, Gunnar, et al.
Publicado: (2020)

Unexpected death in children with severe congenital heart defects in Norway 2004–2016
por: Wik, Gunnar, et al.
Publicado: (2021)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers
por: Khatib, Rani, et al.
Publicado: (2019)

Adherence to secondary prevention recommendations after coronary artery bypass graft surgery
por: Keating, Taya, et al.
Publicado: (2022)

Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
por: Hegde, Nischal N., et al.
Publicado: (2022)

Long‐term outcomes in patients with normal coronary arteries, nonobstructive, or obstructive coronary artery disease on invasive coronary angiography
por: Hanson, Christopher A., et al.
Publicado: (2021)

Sustainability of effects and secondary long-term outcomes: One-year follow-up of a cluster-randomized controlled trial to prevent maltreatment in institutional care
por: Hecker, Tobias, et al.
Publicado: (2022)

The effect of an expanded long-term periodization exercise training on physical fitness in patients with coronary artery disease: study protocol for a randomized controlled trial
por: Pinto, Rita, et al.
Publicado: (2019)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Tianyu, et al.
Publicado: (2021)

Socioeconomic Factors, Secondary Prevention Medication, and Long‐Term Survival After Coronary Artery Bypass Grafting: A Population‐Based Cohort Study From the SWEDEHEART Registry
por: Nielsen, Susanne J., et al.
Publicado: (2020)

Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
por: Mueller, Linda, et al.
Publicado: (2022)

Long-term outcome of coronary artery dilatation in Kawasaki disease
por: Advani, Najib, et al.
Publicado: (2018)

Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial
por: Voong, K. Ranh, et al.
Publicado: (2017)

Long-term effects of percutaneous coronary intervention versus coronary artery surgery in elderly with multi-vessel coronary artery disease
por: Kamal, Amr, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qp0fqgffbgvsnhtp7ae3b4ilf0